CVM

CEL SCI CORP

NYSE · Biological Products, (No Diagnostic Substances) · Inc. CO · CIK 0000725363
$1.08 -2.70% $9.2M
High Impact Filing (7/10)
Vol
Market Cap$9.2M
Cap SizeNano Cap
Inst. Holders13 funds
Inst. Value$1.5M
Inst. Activity1 buys / 1 sells
Insider Activity2B / 0S
Insider Net $$479.0K
Reddit Sentiment60° Warm
SEC Reports4
Exchange NYSE·Sector Biological Products, (No Diagnostic Substances)·Inc. CO·CIK 0000725363·Prev Close $1.11

Recent Activity

May 14, 2026 SEC
CEL-SCI (CVM) entered into a distribution and revenue-sharing agreement with Amarox for the registration, commercializat
8-K — Impact 6/10
May 14, 2026 Insider
KERSTEN GEERT R bought 300,000 shares
Chief Executive Officer @ $1.20 ($360.0K)
May 13, 2026 SEC
CEL-SCI Corporation closed a best-efforts public offering of 6,000,000 shares at $1.20 per share, raising $7.2 million i
8-K — Impact 7/10
May 13, 2026 Insider
KERSTEN GEERT R bought 100,000 shares
Chief Executive Officer @ $1.19 ($119.0K)
May 12, 2026 earnings_calendar
CVM Q2 2026 Earnings Scheduled — 2026-05-12
May 1, 2026 SEC
CEL-SCI filed Amendment No. 1 to its S-1 for a best-efforts offering of up to 4,885,993 shares at $3.07/share, with net
S-1/A — Impact 6/10
Mar 31, 2026 Insider
KERSTEN GEERT R was granted 1,682 shares
Chief Executive Officer @ $3.21 ($5.4K)
Inst.
RENAISSANCE TECHNOLOGIES LLC — DOUBLED
35,890 shares ($115.2K)

Price Targets

Historical data — last covering-analyst action Jul 2023. No current recommendation available.
$25.00 (Jul 2023)
Current $1.69 Low $25.00 Median $25.00 High $25.00 1 analysts
$25.00 $25.00

Analyst Ratings

Historical distribution80% buy · 5 analysts · last covering-analyst action Jul 2023
1Strong Buy
3Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Jul 12, 2023 EF Hutton REITERATE Buy → Buy
Mar 9, 2023 EF Hutton REITERATE Buy
Dec 29, 2022 EF Hutton MAINTAIN Buy
Apr 7, 2022 EF Hutton INITIATE Buy
Jan 13, 2020 HC Wainwright & Co. INITIATE Buy

Top Institutional Holders

FundValueMove
ROYAL BANK OF CANADA
VANGUARD CAPITAL MANAGEMENT LLC$782.1K
VANGUARD FIDUCIARY TRUST CO$157.4K
BlackRock, Inc.$138.9KTRIM
BANK OF AMERICA CORP$131.6K

Recent Insider Trades

DateInsiderTypeValue
May 14, 2026KERSTEN GEERTBUY$360.0K
May 13, 2026KERSTEN GEERTBUY$119.0K
Mar 31, 2026KERSTEN GEERTA$5.4K
Mar 31, 2026TALOR EYALA$2.4K
Mar 31, 2026PRICHEP PATRICIAA$4.3K

Reddit Sentiment

60°
Warm
Bearish Neutral Bullish
1 mentions 1 bullish 0 bearish
13 institutional holders with $1.5M total value (469,128 shares) as of 2026-Q1. Top holders: ROYAL, VANGUARD, VANGUARD.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1ROYAL BANK OF CANADA62$0.000.0%
2VANGUARD CAPITAL MANAGEMENT LLC243,645$782.1K51.9%
3VANGUARD FIDUCIARY TRUST CO49,036$157.4K10.5%
4BlackRock, Inc.43,261$138.9K9.2%TRIM -68.2%
5BANK OF AMERICA CORP /DE/40,997$131.6K8.7%
6RENAISSANCE TECHNOLOGIES LLC35,890$115.2K7.7%DOUBLED +133.0%
7STATE STREET CORP27,270$87.5K5.8%
8COMMONWEALTH EQUITY SERVICES, LLC17,622$56.6K3.8%NEAR_EXIT -87.6%
9HighTower Advisors, LLC10,000$32.1K2.1%
10WELLS FARGO & COMPANY/MN766$2.5K0.2%
11Vanguard Global Advisers, LLC536$1.7K0.1%
12MORGAN STANLEY39$125.000.0%TRIM -33.9%
13Allworth Financial LP4$13.000.0%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
RENAISSANCE TECHNOLOGIES LLCDOUBLED15,40635,890+133.0%$115.2K2026-Q1
MORGAN STANLEYTRIM5939-33.9%$125.002026-Q1
BlackRock, Inc.TRIM136,08743,261-68.2%$227.6K2025-Q4
COMMONWEALTH EQUITY SERVICES, LLCNEAR_EXIT175,20921,683-87.6%$114.0K2025-Q4
MORGAN STANLEYNEAR_EXIT47359-87.5%$310.002025-Q4
VANGUARD GROUP INCADD183,211292,563+59.7%$2.7M2025-Q3
UBS Group AGTRIM29,81715,524-47.9%$142.8K2025-Q3
3 unique insiders with 5 transactions. Net insider value: $479.0K ($479.0K bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 14, 2026KERSTEN GEERT RChief Executive OfficerBUY300,000$1.20$360.0K
May 13, 2026KERSTEN GEERT RChief Executive OfficerBUY100,000$1.19$119.0K
Mar 31, 2026KERSTEN GEERT RChief Executive OfficerAWARD1,682$3.21$5.4K
Mar 31, 2026TALOR EYALChief Scientific OfficerAWARD747$3.21$2.4K
Mar 31, 2026PRICHEP PATRICIA BChief Financial OfficerAWARD1,336$3.21$4.3K

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Jul 2023): 80% buy across 5 analysts — 1 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Jul 2023. No current recommendation available.
$25.00 mean target (Jul 2023)
$25.00 Low $25.00 High
MetricValue
Current Price$1.69
Target Low$25.00
Target Mean$25.00
Target Median$25.00
Target High$25.00
# Analysts1
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2026-09-30
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
5 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 5 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Jul 12, 2023 EF Hutton REITERATE Buy Buy
Mar 9, 2023 EF Hutton REITERATE Buy
Dec 29, 2022 EF Hutton MAINTAIN Buy
Apr 7, 2022 EF Hutton INITIATE Buy
Jan 13, 2020 HC Wainwright & Co. INITIATE Buy
Feb 20, 2013 Taglich Brothers INITIATE Speculative Buy
Feb 13, 2013 Chardan Capital INITIATE Buy
Jan 14, 2013 Laidlaw & Co. INITIATE Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20261310080%
May 1, 20261310080%
Apr 1, 20261310080%
Mar 1, 20261310080%
Feb 1, 20261310080%
Jan 1, 20261310080%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

60°
Warm
Bearish Neutral Bullish
1 mentions 1 bullish 0 bearish 1 time period

Reddit Sentiment History

DateMentionsSentimentBullishBearishThreads
Jun 2, 2026160° Warm101
May 12, 2026
earnings_calendar
CVM Q2 2026 Earnings Scheduled — 2026-05-12
May 12, 2026
short_volume
Short Volume: CVM — 61.5% short (1.4M / 2.3M)
Short: 1,431,635 | Exempt: 369,242 | TRF Vol: 2,327,185 | Short Ratio: 61.5% | Off-exchange volume (dark pool + OTC)
May 11, 2026
short_volume
Short Volume: CVM — 84.8% short (0.5M / 0.5M)
Short: 455,650 | Exempt: 348 | TRF Vol: 537,609 | Short Ratio: 84.8% | Off-exchange volume (dark pool + OTC)
May 4, 2026
short_volume
Short Volume: CVM — 76.7% short (0.5M / 0.7M)
Short: 509,528 | Exempt: 14,688 | TRF Vol: 664,388 | Short Ratio: 76.7% | Off-exchange volume (dark pool + OTC)